Rare diseases
Investigational molecules
Locations
126 East Lincoln Avenue, P. O. Box 2000, 07065-4607, United States
Merck Sharp & Dohme LLC funds a broad oncology portfolio centered on immune checkpoint inhibition and combination regimens across solid tumors and hematologic malignancies. Its studies include disease areas such as non-small cell lung cancer, melanoma, bladder cancer, breast cancer, colorectal cancer, gastric and gastroesophageal junction adenocarcinoma, and head and neck squamous cell carcinoma.
Research also extends to perioperative, adjuvant, and metastatic cancer settings, with interest in KRAS-mutant, PD-L1–expressing, and DNA repair–deficient tumors.
Merck Sharp & Dohme LLC runs clinical trials in conditions such as Non-small cell lung cancer, Neoplasm, Renal cell carcinoma, HIV infection, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
Bulgaria
Austria
CzechiaAustria
DenmarkFranceDenmarkFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
